Hearing loss is a common sensory impairment that affects 278 million people worldwide (1) . Dominant and recessive alleles account for approximately half of congenital or early onset childhood hearing loss that can have a broad range of severity (2) . A majority of pathogenic recessive variants of genes associated with hearing loss cause congenital or prelingual, severe to profound, stable sensorineural deafness, which occurs in approximately 1 in 1000 births (1) . Autosomal dominant inheritance is typically associated with post-lingual, progressive hearing loss that can range from mild to profound at onset or over the course of many decades. In general, the hearing loss associated with dominant inheritance is less severe than that associated with recessive inheritance. A few mutant alleles of some profound deafness-associated genes such as MYO7A and CDH23, have been described to cause variable audiological phenotypes as well (3) (4) (5) . The objective of this study was to determine if other genes previously associated with profound deafness also contribute to moderate or severe hearing loss. Our study implicates 21 different genes as well as modifiers in the etiology of recessively inherited moderate to severe hearing loss.
Materials and methods

Families
The study was approved by the Institutional Review Board at the School of Biological Sciences, University of the Punjab, Lahore and the Combined Neuroscience Institutional Review Board (protocol OH-93-N-016) at the National Institutes of Health, USA. Samples were collected with written informed consent from each participant.
We ascertained 92 consanguineous Pakistani families; 90 residing in the province of Punjab and two families from Khyber Pakhtunkhwa. Probands were identified through special schools in Punjab where children with different disabilities are educated, from schools for the deaf and through referrals from audiologists. In order to identify probands from schools, we first inquired about the extent of a child's hearing ability from teachers, which were verified by a distraction test that involves recording a subject's response to sound stimuli coming from a hidden source. Pure tone thresholds of the probands and other family participants, who expressed willingness for audiometric testing, were measured at 0.25, 0.5, 1, 2, 4 and 8 kHz in a quiet room due to the lack of a sound proof room. The pure-tone average (PTA) was calculated by averaging the hearing thresholds at 0.5, 1, 2 and 4 kHz (6). Hearing loss was classified on the basis of PTA as moderate (41-70 dB HL), severe (71-95 dB HL), and profound (above 95 dB HL) (6) . Individuals with hearing thresholds between 31 and 40 dB HL were classified with mild hearing loss while those with thresholds up to 30 dB HL were considered to have normal hearing as performing audiometry in ambient noise conditions may result in slightly elevated thresholds for those with normal hearing (7) . Subjects were questioned about the age of the onset and progression in severity of their hearing loss. Vestibular function was evaluated by tandem-gait and Romberg tests. Otoscopic examinations and medical histories were completed in order to exclude affected individuals due to active external or middle ear disease, and syndromic or environmental causes, though families with Usher syndrome were included. Funduscopy and electroretinography examinations were conducted for the oldest affected individuals in a subset of families.
Molecular characterization
Blood samples were collected from the participants and genomic DNA was extracted by a standard method (8) . The sequence of GJB2 was analyzed for the affected participants from all families by Sanger sequencing (9) . DNA samples from at least three affected individuals from 66 of 92 consanguineous families (Table  S1 , Supporting information) were screened for linkage to genes associated with non-syndromic recessively inherited deafness (DFNB) and Usher syndrome (USH), by homozygosity mapping as described (10, 11) . In brief, samples from at least three affected individuals were chosen from each family, two to five tightly linked microsatellite markers for each deafness gene were polymerase chain reaction (PCR) amplified using fluorescently tagged primers and the amplicons resolved by capillary electrophoresis. If affected individuals were homozygous for alleles of any of these markers, samples from all participants of the respective family were genotyped for the linked, as well as additional downstream or upstream markers to determine if there is cosegregation with the phenotype.
After homozygosity mapping, Sanger sequencing of the implicated genes was performed for 17 of the families (Table S1 ). Samples from 53 families were screened with massively parallel sequencing (Table S1 ). For targeted capture and massively parallel sequencing of 108 genes with a demonstrated role in hearing (Table S2) , custom probes were designed to capture the exons and approximately 50 bp of flanking intronic sequence. Fragment library preparation and target enrichment were performed according to the manufacturers' instructions on one randomly selected sample from each family (Table  S3 ) and sequencing was performed on an ABI SOLiD 5500. (Applied Biosystems, Carlsbad, CA, USA).
For whole-exome sequencing, one to three samples of affected individuals were randomly selected from the chosen families (Table S3) . Fragment libraries were prepared with a Nextera Rapid Capture library kit (REF#15034786) (Illumina, San Diego, CA, USA) for paired end, dual index sequencing on an Illumina HiSeq 1000 platform at the NIDCD, USA, while some libraries were prepared and sequenced at Otogenetics, USA on an Illumina HiSeq 2000 platform. Variants were annotated using the web-based software wannovar (http://wannovar.usc.edu/). Variants with overall population allele frequencies of >1% (0.01) in any of the public databases (1000 genome dataset, 6500 exome variant server, and Exome Aggregation Consortium, ExAC, database) were removed. Only variants in protein coding sequences or those affecting splice sites were considered further. For HGF (OMIM 142409), we also screened for the intronic variants that were shown to be associated with non-syndromic deafness DFNB39 (OMIM 608265) (12) .
All suspected pathogenic variants were evaluated for cosegregation with the hearing loss phenotype in families by PCR amplification and Sanger sequencing using Big Dye Terminator V3.1 (Applied Biosystems, Foster City, CA). Sequences of PCR primers are available on request. Allele frequencies of the novel variants were assessed by Sanger sequencing using genomic DNA from 100 to 200 ethnically matched unrelated individuals from Pakistan with threshold for assigning the variant as a polymorphism set to its detection in at least 1% control chromosomes. The pathogenicity of the missense variants was evaluated using in silico tools provean (http://provean.jcvi.org/), sift (http://sift.bii.astar.edu.sg/), and mutation taster (http://www. mutationtaster.org/). Possible splicing effects introduced by variants identified near exon/intron junctions were determined by human splicing finder (http:// www.umd.be/HSF/) and skippy (http://research.nhgri. nih.gov/skippy/). Alignments of multiple protein sequences were performed with clustal omega (http:// www.ebi.ac.uk/Tools/msa/clustalo/). The sequences of orthologs for alignment of proteins were obtained from UCSC genome server (https://genome.ucsc.edu/).
Calculation of percentage contributions and confidence intervals
Individuals from 92 families participated in the study. Percentage contribution of deafness genes to hearing loss in this cohort were calculated based on 91 families which included 7 families for which linkage of hearing loss was detected to a reported deafness locus but a pathogenic variant was not identified. The 95% confidence intervals for contribution of genes to deafness were calculated as described (https://onlinecourses.science. psu.edu/stat200/node/48). A family with an USH1C variant was excluded from these calculations as Usher syndrome was manifested by the affected participants at the time of enrollment, and therefore for this family only the reported genes for Usher syndrome were analyzed.
Results
Families
Most of the families we studied had multiple affected individuals who were born to unaffected parents with consanguineous marriages. Exceptions occurred in five families, in which one (HLGM10, HLAI-10, HLAI-19, and HLAI-20) or both parents (HLM1) were also affected, with clear evidence for autosomal recessive inheritance of hearing loss in other branches of the respective pedigrees. Hearing loss in 71 families was moderate or severe ( Fig. 1a-d and Table 1 ). Another 20 families had a majority of individuals with moderate or severe hearing loss while one to three affected individuals presented profound deafness ( Table 1 ). The remaining one family (HLM1) had five members affected with profound deafness at the time of enrollment, which was said to have developed in all individuals gradually from a mild hearing loss in childhood. In most cases, previous audiograms were not available and the age of onset of hearing loss could not be reliably ascertained, though the hearing loss was reported to be progressive in nature for 87 individuals in 22% of the participating families ( Table 1) . None of the affected individuals exhibited an imbalance on tandem gait or Romberg tests.
Genetic analyses
We identified 20 previously described and 21 novel pathogenic variants in reported deafness-associated genes for 57 of the 92 participating families (Table 1) . For seven families, either a gene had not been identified for the implicated locus or no mutations in the reported exons of the corresponding genes were found although the phenotype was linked to markers of a deafness locus for which there are well-documented pathogenic alleles (Table 1) . Of the 20 variants identified in this study that were previously reported to cause deafness (Table  S4) , 15 were present in the public nucleotide variant databases with overall allele frequencies ranging from 0.0000082 to 0.00024 (Table S5) . These variants were rare in the South Asian population as well, except for the p.W24X variant in GJB2 with an allele frequency of 0.004 and the p.V239D variant of SLC26A4 with an allele frequency of 0.0017.
None of the 21 novel pathogenic mutations were detected in the DNA of ethnically matched controls (200-400 chromosomes) but 5 of these were identified in the ExAC database and had an overall allele frequency of 0.000008237-0.00005447 (Table S5 ). The novel variants reported in our study have been deposited in the ClinVar database (http://www.ncbi.nlm.nih. gov/clinvar/).
Novel variants and involvement with moderate or severe hearing loss
We identified novel variants in 13 known deafness-associated genes in 21 of the 92 participating families (Table 1) . Fifteen of the 21 variants Variable degree of mild-to-moderate, moderate-to-severe, or moderate-to-profound hearing loss in family HLGM24 due to CDH23 missense mutation. (b) Moderate, moderate-to-severe, or moderate-to-profound hearing loss in family HLAI-16 due to MYO6 frameshift mutation. (c) Mild-to-moderate, moderate, and moderate-to-severe hearing loss as observed in family HLGM19 which had a frameshift variant in TECTA. Note that one of the affected individuals has a significantly lesser degree of hearing loss (d) Moderate-to-severe or severe-to-profound hearing loss was present in family HLAI-22. The parents reported that the affected individuals had a progressive hearing loss.
are described in this manuscript (Table 1 , Supporting information) while the other six variants were reported earlier by us (Tables 1 and S4 ). These variants (Table 1) did not differ substantially from those previously reported in the type of mutation or predicted pathogenicity ( Fig. 2 , Supporting information). The variants of TRIOBP, ESPN and MYO6 described here implicate for the first time these genes in recessively inherited moderate or severe hearing loss. Though specific mutations of MYO15A and CDH23 are known to be involved with moderate or severe hearing loss (3, (13) (14) (15) , some of the variants we identified do not correspond to the established genotype-phenotype correlations for these genes (Supporting information). For example, we found that homozygous mutations that affected both isoforms 1 and 2 of MYO15A (16) were associated with severe hearing loss ( Table 1 , Supporting information). This is in contrast to earlier findings in which it was hypothesized that mutations which affect both isoforms of MYO15A would result in profound deafness (13, 14) .
We also found mutations in genes which are established causes of moderate to severe hearing loss (Supporting information) such as TECTA and PTPRQ (17, 18) . It has been stated that PTPRQ mutations show weak evidence for association to deafness (19) . However, different studies (18, (20) (21) (22) (23) and the frameshift variant identified in three affected cousins in a participating family in our research (Table 1) together establish PTPRQ as a bona fide deafness gene.
Known variants as cause of moderate or severe hearing loss SLC26A4 (OMIM 605646) variants were the most numerous in our cohort, associated with hearing loss in 12 families and in one of the eight affected individuals in family HLAM12B. We found the same five nonsense, missense and frameshift mutations (24) ( Table 1) as cause of the moderate or severe hearing loss, which were previously reported to result in profound deafness in other studies (Table S5, Fig. 3 ). Audiometric thresholds among individuals homozygous for these SLC26A4 variants were not significantly correlated with age (ages 6-45 years, Spearman's r = 0.226; p = 0.11) suggesting that other genetic or environmental factors can modify the phenotype associated with these mutations (Fig. 3) . For example, an 18-year-old individual in family HLAI-20 had profound deafness (PTA 104 dB HL) in contrast to the other older individuals in his family (ages 45 and 35 years; PTA 84 and 89 dB HL, respectively). Similarly, in families HLAI-15 and HLAM01B in which the affected individuals were homozygous for the p.Q446R variant of SLC26A4, the 25 and 26-year-old individuals have better hearing (PTA 73 and 83 dB HL, respectively) as compared with the younger affected individuals (ages 10 and 12 years, PTA 104 and 98 dB HL, respectively). The type of mutation was also not correlated to the severity of the phenotype as three individuals homozygous for a nonsense (p.Ser57X) or a frameshift (c.965dupA) mutation in SLC26A4 had moderate hearing loss (PTA 66, 63 and 69 dB HL) at the ages of 12, 25 and 28 years, respectively (Table 1, Fig. 3 ). In addition to SLC26A4, some known variants of other genes including GJB2 (OMIM 121011), MYO15A and TMPRSS3 (OMIM 605511), were found segregating with moderate or severe hearing loss in this study but were previously reported as a cause of profound deafness (Table 1 , Supporting information). Comparison of audiograms of affected individuals with identical mutations in multiple families did not suggest that the observed hearing threshold differences were age related.
It has been hypothesized that homozygosity for TMPRSS3 frameshift variants results in profound deafness (25) . We identified a homozygous frameshift mutation as a cause of moderate or severe hearing loss in one participating family (Table 1 , Supporting information). In addition, the age of onset of hearing loss in one family with a cryptic acceptor splice site variant in intron 4 of TMPRSS3 (Table 1) was between 3 and 4 years and was moderate to severe at the age of 22 years in contrast to the deafness progressing to profound degree in two families with the identical mutation (26) (Supporting information).
Molecular heterogeneity
In families HLAI-05, HLAI-18, HLAI-20, HLAI-27, HLAM01A, HLAM12B and HLMR3, some of the affected individuals were not homozygous for the pathogenic mutation found in deaf siblings or close relatives (Fig. S1 ), indicating that variants of other genes or environmental factors contribute to their hearing loss. together accounted for hearing loss in 54% of the families (Table 3) . Variants of other genes were rare and collectively accounted for the phenotype in 15% of the families (Table 3) .
Discussion
Persons with hearing loss of moderate or severe degree may derive satisfactory benefit from hearing aids, while cochlear implantation is a recommended treatment to restore access to sound for individuals with profound deafness. As profound deafness is clinically distinct from moderate and severe hearing loss, we hypothesized that there would be a spectrum of variants of unique deafness genes as well as distinct mutant alleles of the reported deafness genes as causes of moderate to severe hearing loss. Although we did discover mutations of GRXCR2 (OMIM 615762) (27) and MET (OMIM 164860) (28) as novel causes of progressive or severe hearing loss, unexpectedly we found that exactly the same mutations previously reported to be associated with profound deafness can also cause moderate to severe hearing loss. In fact, the combined contribution of SLC26A4 and GJB2 to moderate or severe hearing loss in this cohort is as high as 24.2% in contrast to that of 13.35% due to the mutant alleles of these same two genes to profound deafness in Pakistan (29) . Phenotypic variability due to mutations in the same gene is usually attributed to a difference in severity of gene function disruption. Splice site variants not resulting in a complete loss of the protein and missense mutations can sometimes be less damaging than nonsense and frameshift mutations. However, of the 41 mutations that we identified in reported deafness genes, 7 are nonsense (17%), 11 cause frameshifts in the canonical reading frames (27%), 5 are splice site mutations (12%), 2 are in-frame deletions (5%), 1 is a regulatory variant (2%) and the remaining 15 are missense mutations (37%). The splice site mutations of MYO15A and USH1G are predicted to result in the loss of the encoded proteins. Phenotypic variation for the same mutant allele suggests the presence of genetic modifiers, environmental factors or both. We did not find variants in the mitochondrial genome that might account for phenotypic variability observed in families in which affected individuals had identical mutations. In addition, we found no rare variants of ATP2B2, a known modifier gene of CDH23-related deafness (15) . The possibility remains to be explored that common variants of ATP2B2 are modifiers.
Few studies have reported population wide involvement of specific genes in moderate or severe hearing loss. For example, copy number variations and point mutations of STRC (OMIM 606440) contributed to approximately 6% of mild to moderate hearing loss in the United States and Germany in a cohort of 763 individuals (30, 31) . In Qatar, GJB2 variants accounted for 15% of moderate to severe hearing loss in a cohort of 126 individuals (32) . Our work has indicated the involvement of 23 genes in the genetics of moderate or severe hearing loss and implicates modifiers in reducing the severity of the phenotype. Future molecular genetic insight and epidemiological studies may be helpful in identifying specific modifier variants in the genetic background of our study subjects which, perhaps in combination with extrinsic factors, partially suppress profound deafness.
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